202 related articles for article (PubMed ID: 33638003)
21. The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination.
Brown AH; Shah S; Groves AM; Wan S; Malhotra A
Clin Nucl Med; 2021 Dec; 46(12):1006-1010. PubMed ID: 33795590
[TBL] [Abstract][Full Text] [Related]
22. Evolving Bilateral Hypermetabolic Axillary Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination.
Weeks JK; O'Brien SR; Rosenspire KC; Dubroff JG; Pantel AR
Clin Nucl Med; 2021 Dec; 46(12):1011-1012. PubMed ID: 34735411
[TBL] [Abstract][Full Text] [Related]
23. Resolution of Misleading COVID-19 Vaccination-Related Nodal and Splenic FDG Uptake in the Follow-up Study.
Bhimaniya S; Jahromi A
Clin Nucl Med; 2022 Oct; 47(10):e658-e659. PubMed ID: 35619209
[TBL] [Abstract][Full Text] [Related]
24. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
Smith MV; Yang M
J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
[TBL] [Abstract][Full Text] [Related]
25. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
26. Misleading FDG Uptake in Oncology Assessment: Beyond COVID-19 Vaccination-The Role of Pneumococcal Vaccination.
Moreau A; Mognetti T; Kryza D
Clin Nucl Med; 2024 Mar; 49(3):283-284. PubMed ID: 38306382
[TBL] [Abstract][Full Text] [Related]
27. COVID-19 vaccination effect on tracer uptake with FDG-PET/CT.
Lee HJ
QJM; 2021 Nov; 114(9):675. PubMed ID: 34297113
[No Abstract] [Full Text] [Related]
28. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 Vaccination Manifesting as Incidental Lymph Nodal Uptake on 18F-FDG PET/CT.
Ahmed N; Muzaffar S; Binns C; Ilyas MW; Usmani S
Clin Nucl Med; 2021 May; 46(5):435-436. PubMed ID: 33661193
[TBL] [Abstract][Full Text] [Related]
30. FDG-Avid Ipsilateral Iliac and Inguinal Lymphadenopathy After COVID-19 Vaccination With Thigh Injection.
Bass D; Puri S
AJR Am J Roentgenol; 2022 Jan; 218(1):180. PubMed ID: 34259040
[No Abstract] [Full Text] [Related]
31. Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine.
Landete E; Gómez-Fernández I; González-Gascón-Y-Marín I; Durán-Barquero C; Churruca J; Infante MS; Muñoz-Novas C; Foncillas MÁ; Marín K; Ramos-de-Ascanio V; Alonso-Farto JC; Hernández-Rivas JÁ
Hum Vaccin Immunother; 2021 Dec; 17(12):5129-5132. PubMed ID: 34920695
[TBL] [Abstract][Full Text] [Related]
32. Beyond Covid-19 vaccination-associated pitfalls on [
Bauckneht M; Aloè T; Tagliabue E; Cittadini G; Guadagno A; Morbelli S; Barisione E
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2661-2662. PubMed ID: 33876261
[No Abstract] [Full Text] [Related]
33. The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on
El-Sayed MS; Wechie GN; Low CS; Adesanya O; Rao N; Leung VJ
Clin Med (Lond); 2021 Nov; 21(6):e633-e638. PubMed ID: 34862224
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG-Avid Lymph Nodes After COVID-19 Vaccination on 18F-FDG PET/CT.
Ulaner GA; Giuliano P
Clin Nucl Med; 2021 May; 46(5):433-434. PubMed ID: 33782318
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination.
İşgören S; Köroğlu G; Görür GD; Demir H
Turk J Med Sci; 2022 Dec; 52(6):1745-1753. PubMed ID: 36945983
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting the accuracy of
Kutluturk K; Simsek A; Comak A; Gonultas F; Unal B; Kekilli E
Niger J Clin Pract; 2019 Jan; 22(1):63-68. PubMed ID: 30666022
[TBL] [Abstract][Full Text] [Related]
37. Utility of 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography/computed tomography scan in the systemic evaluation of patients with post-COVID-19 endogenous presumed fungal endophthalmitis.
Mehta S; Nagvekar V; Gupta G
Indian J Ophthalmol; 2021 Oct; 69(10):2873-2874. PubMed ID: 34571657
[No Abstract] [Full Text] [Related]
38. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
39. [
Kubota K; Saginoya T; Ishiwata K; Nakasato T; Munechika H
Ann Nucl Med; 2022 Apr; 36(4):340-350. PubMed ID: 35098436
[TBL] [Abstract][Full Text] [Related]
40. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
